Sinocare Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Sinocare kazanç ve gelirin sırasıyla yıllık 34.9% ve 12.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 34.5% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 13.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

34.9%

Kazanç büyüme oranı

34.5%

EPS büyüme oranı

Medical Equipment kazanç büyümesi	27.5%
Gelir büyüme oranı	12.3%
Gelecekteki özkaynak getirisi	13.3%
Analist kapsamı	Good
Son güncelleme	30 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

SZSE:300298 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	5,577	587	621	789	5
12/31/2025	4,938	460	548	604	6
12/31/2024	4,434	371	313	572	6
9/30/2024	4,206	222	476	729	N/A
6/30/2024	4,184	307	353	711	N/A
3/31/2024	4,190	306	303	657	N/A
12/31/2023	4,059	284	389	735	N/A
9/30/2023	4,137	379	241	578	N/A
6/30/2023	4,110	392	470	755	N/A
3/31/2023	4,215	441	434	760	N/A
1/1/2023	3,952	447	362	682	N/A
9/30/2022	3,463	296	485	803	N/A
6/30/2022	3,081	218	258	610	N/A
3/31/2022	2,478	128	171	475	N/A
1/1/2022	2,361	108	76	480	N/A
9/30/2021	2,235	134	-58	366	N/A
6/30/2021	2,174	147	-22	365	N/A
3/31/2021	2,095	168	28	435	N/A
12/31/2020	2,015	187	229	505	N/A
9/30/2020	2,049	287	324	566	N/A
6/30/2020	1,936	280	245	502	N/A
3/31/2020	1,831	265	273	517	N/A
12/31/2019	1,778	251	101	523	N/A
9/30/2019	1,651	286	-26	474	N/A
6/30/2019	1,604	272	66	534	N/A
3/31/2019	1,607	276	-72	368	N/A
12/31/2018	1,551	310	77	319	N/A
9/30/2018	1,429	286	-22	116	N/A
6/30/2018	1,301	333	N/A	59	N/A
3/31/2018	1,112	296	N/A	158	N/A
1/1/2018	1,033	258	N/A	244	N/A
9/30/2017	994	206	N/A	270	N/A
6/30/2017	945	156	N/A	272	N/A
3/31/2017	849	116	N/A	223	N/A
12/31/2016	796	115	N/A	203	N/A
9/30/2016	722	138	N/A	231	N/A
6/30/2016	674	121	N/A	180	N/A
3/31/2016	698	155	N/A	183	N/A
12/31/2015	646	144	N/A	122	N/A
9/30/2015	634	176	N/A	164	N/A
6/30/2015	611	191	N/A	170	N/A
3/31/2015	570	199	N/A	147	N/A
12/31/2014	545	197	N/A	153	N/A
9/30/2014	506	191	N/A	131	N/A
6/30/2014	488	176	N/A	133	N/A
3/31/2014	450	157	N/A	128	N/A
12/31/2013	449	165	N/A	114	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 300298 'nin tahmini kazanç büyümesi (yıllık 34.9% ) tasarruf oranının ( 2.9% ) üzerindedir.

Kazançlar ve Piyasa: 300298 şirketinin kazançlarının (yıllık 34.9% ) CN pazarından (yıllık 25.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 300298 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 300298 şirketinin gelirinin (yıllık 12.3% ) CN pazarından (yıllık 14.1% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 300298 şirketinin gelirinin (yıllık 12.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 300298 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 13.3 %).

Sinocare Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates fall by 11%

Price target decreased by 8.0% to CN¥31.01

Price target decreased by 14% to CN¥33.71

Price target increased to CN¥39.34

Consensus forecasts updated

Price target decreased to CN¥20.73

Recent updates

We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Consensus EPS estimates fall by 11%

New minor risk - Profit margin trend

Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Investor sentiment deteriorates as stock falls 15%

Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return

New minor risk - Share price stability

Sinocare Inc. to Report Q3, 2024 Results on Oct 24, 2024

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 2Q 2023)

Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Price target decreased by 8.0% to CN¥31.01

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Now 21% undervalued after recent price drop

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Price target decreased by 14% to CN¥33.71

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to CN¥39.34

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to CN¥20.73

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

Price target decreased to CN¥40.66

Consensus forecasts updated

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥46.30

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

Kazanç ve Gelir Büyüme Tahminleri